ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update

2017

Journal of Crohn's and Colitis , Volume 11 - Issue 1 p. 26- 34

Additional Metadata
Persistent URL	doi.org/10.1093/ecco-jcc/jjw198, hdl.handle.net/1765/108512
Journal	Journal of Crohn's and Colitis
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Danese, S., Fiorino, G. (Gionata), Raine, T. (Tim), Ferrante, M., Kemp, K., Kierkus, J., Lakatos, P.L. (Peter L.), Mantzaris, G., van der Woude, J. (Janneke), Panes, J.& Peyrin-Biroulet, L. (2017). ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update. Journal of Crohn's and Colitis, 11(1), 26–34.https://doi.org/10.1093/ecco-jcc/jjw198

Publication